Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.meghmanifinechem.com | |
Market Cap | 4,057.37 Cr. | |
Enterprise Value(EV) | 4,866.47 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 66.67 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 14.63 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 33.54 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 264.93 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 3.68 | Calculated using Price: 975.40 |
Dividend Yield | 0.51 | Period Ending 2023-03 |
No. of Shares Subscribed | 4.16 Cr. | 41,550,158 Shares |
FaceValue | 10 | |
About Epigral Ltd. | ||
The Company is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products. |
1 Day |
|
+1.14% |
1 Week |
|
-2.37% |
1 Month |
|
+10.06% |
3 Month |
|
-12.65% |
6 Month |
|
+16.52% |
1 Year |
|
-30.91% |
2 Year |
|
+36.51% |
5 Year |
|
|
10 Year |
|
3 years | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 21.31 | 42.16 | 39.36 | |
Return on Capital Employed (%) | 15.97 | 29.40 | 32.20 | |
Return on Assets (%) | 6.96 | 14.15 | 15.51 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 684 | 726 | 1,069 | |
Non Curr. Liab. | 376 | 865 | 715 | |
Curr. Liab. | 389 | 532 | 648 | |
Minority Int. | ||||
Equity & Liab. | 1,449 | 2,124 | 2,432 | |
Non Curr. Assets | 1,267 | 1,677 | 2,013 | |
Curr. Assets | 181 | 447 | 420 | |
Misc. Exp. not W/O | ||||
Total Assets | 1,449 | 2,124 | 2,432 |
Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 829 | 1,551 | 2,188 | 2,110 | |
Other Income | 7 | 8 | 9 | 7 | |
Total Income | 836 | 1,559 | 2,198 | 2,118 | |
Total Expenditure | -567 | -1,041 | -1,499 | -1,514 | |
PBIDT | 269 | 518 | 698 | 604 | |
Interest | -34 | -49 | -67 | -73 | |
Depreciation | -74 | -86 | -109 | -118 | |
Taxation | -60 | -131 | -169 | -137 | |
Exceptional Items | |||||
PAT | 101 | 253 | 353 | 277 | |
Minority Interest | |||||
Share Associate | 0 | ||||
Other Related Items | |||||
Consolidated Net Profit | 101 | 253 | 353 | 277 | |
Adjusted EPS | 24 | 61 | 85 | 67 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 229 | 284 | 626 | |
Cash Fr. Inv. | -197 | -455 | -437 | |
Cash Fr. Finan. | -32 | 195 | -200 | |
Net Change | 1 | 24 | -11 | |
Cash & Cash Eqvt | 1 | 25 | 14 |
Thu, 28 Sep 2023
Closure of Trading Window Epigral Limited informs regarding Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 |
Tue, 12 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Epigral Limited informs that the Company is having One-on-one VC with Abans Investment Managers on 13th September 2023. |
Tue, 12 Sep 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Epigral Limited informs that the Company is having One-on-one meeting with Sunidhi Securities & Finance Ltd. on 15th September 2023 at Dahej Plant Gujarat. |
Wed, 27 Sep 2023 |
|
|
|
|
|